BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31468717)

  • 1. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo.
    Cui T; Yan Z; Qin H; Sun Y; Ren J; Qu X
    Small; 2019 Oct; 15(42):e1903323. PubMed ID: 31468717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
    Chen E; Han S; Song B; Xu L; Yuan H; Liang M; Sun Y
    Int J Nanomedicine; 2020; 15():6311-6324. PubMed ID: 32922003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
    Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
    Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic Conjugated Polymer/Hyaluronan-Doxorubicin Complex for Sensitive Fluorescence Detection of Hyaluronidase and Tumor-Targeting Drug Delivery and Imaging.
    Huang Y; Song C; Li H; Zhang R; Jiang R; Liu X; Zhang G; Fan Q; Wang L; Huang W
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21529-37. PubMed ID: 26331442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.
    Zhou H; Fan Z; Deng J; Lemons PK; Arhontoulis DC; Bowne WB; Cheng H
    Nano Lett; 2016 May; 16(5):3268-77. PubMed ID: 27057591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy.
    Hu C; Cun X; Ruan S; Liu R; Xiao W; Yang X; Yang Y; Yang C; Gao H
    Biomaterials; 2018 Jun; 168():64-75. PubMed ID: 29626787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction/Oxidation-Responsive Hierarchical Nanoparticles with Self-Driven Degradability for Enhanced Tumor Penetration and Precise Chemotherapy.
    Yin S; Gao Y; Zhang Y; Xu J; Zhu J; Zhou F; Gu X; Wang G; Li J
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18273-18291. PubMed ID: 32223148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy.
    Liu Y; Dai R; Wei Q; Li W; Zhu G; Chi H; Guo Z; Wang L; Cui C; Xu J; Ma K
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):44582-44592. PubMed ID: 31682097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-stimuli-responsive multi-scale hyaluronic acid nanoparticles for deepened tumor penetration and enhanced therapy.
    Huo M; Li W; Chaudhuri AS; Fan Y; Han X; Yang C; Wu Z; Qi X
    Carbohydr Polym; 2017 Sep; 171():173-182. PubMed ID: 28578951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor.
    Wang X; Xu J; Xu X; Fang Q; Tang R
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():111004. PubMed ID: 32487411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
    Feng T; Ai X; An G; Yang P; Zhao Y
    ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
    Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
    Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoreactive-proton-generating hyaluronidase/albumin nanoparticles-loaded PEG-hydrogel enhances antitumor efficacy and disruption of the hyaluronic acid extracellular matrix in AsPC-1 tumors.
    Lee WT; Lee J; Kim H; Nguyen NT; Lee ES; Oh KT; Choi HG; Youn YS
    Mater Today Bio; 2021 Sep; 12():100164. PubMed ID: 34877519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.